Hepatocyte Growth Factor/hepatopoietin A Stimulates the Growth of Rat Kidney Proximal Tubule Epithelial Cells (RPTE), Rat Nonparenchymal Liver Cells, Human Melanoma Cells, Mouse Keratinocytes and Stimulates Anchorage-independent Growth of SV-40...

Overview

Journal Biochem Biophys Res Commun

Publisher Elsevier

Specialty Biochemistry

Date 1991 Jan 15

PMID 1846541

Citations 60

Authors

M Kan

G H Zhang

R Zarnegar

G Michalopoulos

Y Myoken

W L McKeehan

J I Stevens

Affiliations

Soon will be listed here.

Abstract

Hepatocyte growth factor/hepatopoietin A is a mitogen for primary hepatocytes and may mediate regeneration after liver damage. To date, the activity of this novel factor has been restricted to hepatocytes. We now show that the factor is also a mitogen for a number of primary epithelial cells but is inactive with human foreskin fibroblasts, human endothelial cells and HEP3B cells. The factor also substitutes for HBGF-2 (basic FGF) in stimulating the anchorage-independent growth of SV-40 transformed rat kidney epithelial cells. Therefore, hepatocyte growth factor/hepatopoietin A appears to act on a variety of epithelial, but not mesenchymal, cells which respond to HBGFs.

Citing Articles

Therapeutic advances of targeting receptor tyrosine kinases in cancer.

Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A Signal Transduct Target Ther. 2024; 9(1):201.

PMID: 39138146 PMC: 11323831. DOI: 10.1038/s41392-024-01899-w.

Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges.

Hu C, Zhang Y, Wu C, Huang Q Cell Death Discov. 2023; 9(1):124.

PMID: 37055382 PMC: 10102018. DOI: 10.1038/s41420-023-01428-8.

HGF/c-MET Signaling in Melanocytes and Melanoma.

Czyz M Int J Mol Sci. 2018; 19(12).

PMID: 30513872 PMC: 6321285. DOI: 10.3390/ijms19123844.

Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab.

Kumar D, Kandl C, Hamilton C, Shnayder Y, Tsue T, Kakarala K JAMA Otolaryngol Head Neck Surg. 2015; 141(12):1133-9.

PMID: 26540318 PMC: 4815928. DOI: 10.1001/jamaoto.2015.2381.

Resistance to targeted cancer drugs through hepatocyte growth factor signaling.

Heynen G, Fonfara A, Bernards R Cell Cycle. 2014; 13(24):3808-17.

PMID: 25426675 PMC: 4615055. DOI: 10.4161/15384101.2014.988033.